Press Releases
PSM Statement on Florida’s Submission of Irresponsible Drug Importation Concept Document
WASHINGTON (August 26, 2019) – Shabbir Imber Safdar, Executive Director of The Partnership for Safe Medicines, released the following statement in response to Florida’s submission of a drug importation concept to the U.S. Department of Health and Human Services (HHS): “Florida’s Canadian Prescription Drug Importation Concept Paper [PDF] recently submitted to HHS demonstrates that Florida…
[...]Partnership for Safe Medicines Statement on Reckless and Politically-Motivated Federal Drug Importation Proposal
Partnership for Safe Medicines Statement on Reckless and Politically-Motivated Drug Importation Proposal Washington, D.C. (July 31, 2019) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to today’s announcement by HHS Secretary Alex Azar and FDA Commissioner Ned Sharpless: “Less than a year and a half ago,…
[...]Peer-reviewed journal article estimates 300,000 child fatalities annually due to counterfeit medication
The Partnership for Safe Medicines and the Alliance for Safe Online Pharmacies (ASOP Global), two public health advocacy groups focused on patient safety and the secure pharmaceutical supply chain, released an infographic today to call attention to the human toll that counterfeit medicines take on children in low and middle income countries.
[...]Partnership for Safe Medicines’ Statement on Governor DeSantis Signing Florida’s Drug Importation Bill
Washington, D.C. (June 11, 2019) – Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, released the following statement today in response to the signing of Florida’s drug importation bill: “Today, Florida’s governor put politics over the safety of residents across the state. Although this was widely expected, we remain committed to protecting…
[...]PSM responds to AMA resolution #129 (A-19) on Mexico drug importation – June 9, 2019
Recently the Partnership for Safe Medicines learned of and responded to a proposed resolution for the American Medical Association’s House of Delegates regarding importation of medicine from the Mexican drug supply and PSM’s response. Resolution a19-r129 Benefits of Importation of Pharmaceuticals PSM Response to AMA Resolution_ 129 (importing prescription drugs from Mexico)
[...]Tom Kubic, leading expert in counterfeit medicines re-joins the board of the Partnership for Safe Medicines
“I’m pleased to re-join the Partnership for Safe Medicines’ Board of Directors at a time when factual information concerning the risks posed by medicines reaching unsuspecting Americans is critically needed” said Tom.
[...]Partnership for Safe Medicines’ Statement in Response to President Trump’s Comments on Foreign Drug Importation
Washington, D.C. (May 9, 2019) – Shabbir Safdar, Executive Director of the Partnership for Safe Medicines, released the following statement in response to President Trump’s comments on drug importation: “We have worked on this issue for more than 15 years and it is simply not possible to import medicines safely from a foreign country’s drug…
[...]New PSM ads highlight concerns of FDA Commissioner Gottlieb about the dangers of Florida’s importation legislation
Tallahassee, FL (April 18, 2019) – Today the Partnership for Safe Medicines released new ads to run in several parts of Florida that highlight the dangers of Florida attempting to import medicine from Canada. Five different commissioners of the US Food and Drug Administration, appointed by both Republicans and Democrats, have stated that such proposals are dangerous to patients, will expose them to counterfeits, and are unlikely to reduce the price of medicine.
[...]Partnership for Safe Medicines Launches Advertising Campaign in Florida to Oppose Importation
April 12, 2019 (Tallahassee, FL) — Importation undermines our core efforts to keep our medicine supply safe. State and federal authorities regulate every entity in the U.S. supply chain from the point of manufacture until a medicine is dispensed, and that makes counterfeits in the legitimate supply chain rare. In 2013, Congress passed the Drug…
[...]PRESS RELEASE: Over 100 Organizations Representing Law Enforcement Officers, Healthcare Professionals, Patient Advocates Urge White House and Congress to Reject Prescription Drug Importation
WASHINGTON (April 8, 2019) – As members of Congress and leaders in the executive branch consider steps to allow wholesale importation of prescription medications, organizations representing consumers, employers, healthcare professionals, patients, and law enforcement officers, among others, are insisting that such proposals, if implemented, would endanger the health and safety of the communities throughout the country…
[...]